Céline Vallot

Céline Vallot is a group leader at Institut Curie since 2017. Her lab works on the dynamics of epigenomes in breast cancers during treatment and the early phases of tumorigenesis, combining experimental and computational approaches. Céline is the recipient of ERC Starting and Consolidator Grants and has co-founded the Single-Cell Initiative of Institut Curie, a facility enabling the analysis of single cells in space and times at various scales (DNA, RNA, epigenomes, proteins). She is also the founder of the company One Biosciences that advances clinical single cell profiling to guide treatment decisions, patient selection, and optimize clinical trials.